Clinical Characteristics of Clostridium Difficile-associated Diarrhea Among Patients in a Tertiary Care Center in China

Overview

Journal Pak J Med Sci

Specialty General Medicine

Date 2016 Jul 5

PMID 27375724

Citations 4

Authors

Yongqiang Li

Yi Huang

Yuyuan Li

Yuqiang Nie

Affiliations

Soon will be listed here.

Abstract

Objective: This study investigated the incidence, risk factors, and clinical characteristics of Clostridium difficile-associated diarrhea (CDAD) in Chinese patients.

Methods: Fecal specimens of patients with antibiotic-associated diarrhea (AAD) were collected to test C. difficile toxin A and B using enzyme-linked fluorescent assay to identify CDAD. By adopting a nested case-control design, the matched people (ratio 1:3) without AAD were included as controls.

Results: Out of 56,172 inpatients, 39,882 (71.0%) used antibiotics, 470 suffered from AAD, and 93 were diagnosed with CDAD. The incidence of nosocomial CDAD was 166 per 100,000. The proportion of CDAD in AAD was 19.8%. CDAD patients presented with more severe clinical manifestations and exhibited more concurrent illness. Logistic regression analysis showed the risk factors of CDAD: advanced age, nasogastric tube-feeding, high APACHE II scores, high level of serum C-reaction protein, low level of serum albumin, severe underlining disease or comorbidity, and number of antibiotic intake. Twenty-nine patients (31.2%) were cured with vancomycin, 54 (58.1%) were cured after dual therapy of vancomycin plus metronidazole, 7 (7.5%) died of underlying diseases aggravated with CDAD, and 3 (3.2%) were transferred to other hospitals for personal reasons.

Conclusion: The incidence of nosocomial CDAD in China was high. Some risk factors could predispose CDAD.

Citing Articles

Symptoms, Treatment, and Outcomes of COVID-19 Patients Coinfected with : Single-Center Study from NE Romania during the COVID-19 Pandemic.

Stamateanu L, Miftode I, Plesca C, Dorneanu O, Rosu M, Miftode I Antibiotics (Basel). 2023; 12(7).

PMID: 37508187 PMC: 10375993. DOI: 10.3390/antibiotics12071091.

A worldwide systematic review and meta-analysis of bacteria related to antibiotic-associated diarrhea in hospitalized patients.

Motamedi H, Fathollahi M, Abiri R, Kadivarian S, Rostamian M, Alvandi A PLoS One. 2021; 16(12):e0260667.

PMID: 34879104 PMC: 8654158. DOI: 10.1371/journal.pone.0260667.

Clostridium difficile-associated Diarrhea in Developing Countries: A Systematic Review and Meta-Analysis.

Curcio D, Cane A, Fernandez F, Correa J Infect Dis Ther. 2019; 8(1):87-103.

PMID: 30659481 PMC: 6374231. DOI: 10.1007/s40121-019-0231-8.

The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact.

Borren N, Ghadermarzi S, Hutfless S, Ananthakrishnan A PLoS One. 2017; 12(5):e0176797.

PMID: 28463987 PMC: 5413003. DOI: 10.1371/journal.pone.0176797.

References

Drudy D, Harnedy N, Fanning S, Hannan M, Kyne L . Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile. Infect Control Hosp Epidemiol. 2007; 28(8):932-40. DOI: 10.1086/519181. View

Surawicz C, Brandt L, Binion D, Ananthakrishnan A, Curry S, Gilligan P . Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013; 108(4):478-98. DOI: 10.1038/ajg.2013.4. View

Debast S, van Kregten E, Oskam K, van den Berg T, van den Berg R, Kuijper E . Effect on diagnostic yield of repeated stool testing during outbreaks of Clostridium difficile-associated disease. Clin Microbiol Infect. 2008; 14(6):622-4. DOI: 10.1111/j.1469-0691.2008.01999.x. View

Modena S, Gollamudi S, Friedenberg F . Continuation of antibiotics is associated with failure of metronidazole for Clostridium difficile-associated diarrhea. J Clin Gastroenterol. 2005; 40(1):49-54. DOI: 10.1097/01.mcg.0000190761.80615.0f. View

LeGall J, Loirat P, Alperovitch A . APACHE II--a severity of disease classification system. Crit Care Med. 1986; 14(8):754-5. DOI: 10.1097/00003246-198608000-00027. View

Barbut F, Gariazzo B, Bonne L, Lalande V, Burghoffer B, Luiuz R . Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004. Infect Control Hosp Epidemiol. 2007; 28(2):131-9. DOI: 10.1086/511794. View

Zilberberg M, Shorr A, Kollef M . Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis. 2008; 14(6):929-31. PMC: 2600276. DOI: 10.3201/eid1406.071447. View

Pepin J, Valiquette L, Alary M, Villemure P, Pelletier A, Forget K . Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ. 2004; 171(5):466-72. PMC: 514643. DOI: 10.1503/cmaj.1041104. View

Jin K, Wang S, Huang Z, Lu S . Clostridium difficile infections in China. J Biomed Res. 2013; 24(6):411-6. PMC: 3596688. DOI: 10.1016/S1674-8301(10)60055-3. View

10.

Lv Z, Peng G, Su J . Factors associated with Clostridium difficile diarrhea in a hospital in Beijing, China. Braz J Med Biol Res. 2014; 47(12):1085-90. PMC: 4244675. View

11.

Kuijper E, Coignard B, Tull P . Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect. 2006; 12 Suppl 6:2-18. DOI: 10.1111/j.1469-0691.2006.01580.x. View

12.

Kelly C, Lamont J . Clostridium difficile--more difficult than ever. N Engl J Med. 2008; 359(18):1932-40. DOI: 10.1056/NEJMra0707500. View

13.

DuPont H, Garey K, Caeiro J, Jiang Z . New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control. Curr Opin Infect Dis. 2008; 21(5):500-7. DOI: 10.1097/QCO.0b013e32830f9397. View

14.

Wang X, Cai L, Yu R, Huang W, Zong Z . ICU-Onset Clostridium difficile infection in a university hospital in China: a prospective cohort study. PLoS One. 2014; 9(11):e111735. PMC: 4221109. DOI: 10.1371/journal.pone.0111735. View

15.

McDonald L, Killgore G, Thompson A, Owens Jr R, Kazakova S, Sambol S . An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005; 353(23):2433-41. DOI: 10.1056/NEJMoa051590. View

16.

Loo V, Poirier L, Miller M, Oughton M, Libman M, Michaud S . A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005; 353(23):2442-9. DOI: 10.1056/NEJMoa051639. View

17.

Huang H, Wu S, Wang M, Zhang Y, Fang H, Palmgren A . Molecular and clinical characteristics of Clostridium difficile infection in a University Hospital in Shanghai, China. Clin Infect Dis. 2008; 47(12):1606-8. DOI: 10.1086/593365. View

18.

FEKETY R . Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 1997; 92(5):739-50. View

19.

Moshkowitz M, Ben-Baruch E, Kline Z, Shimoni Z, Niven M, Konikoff F . Risk factors for severity and relapse of pseudomembranous colitis in an elderly population. Colorectal Dis. 2007; 9(2):173-7. DOI: 10.1111/j.1463-1318.2006.01013.x. View

20.

Huang H, Wu S, Chen R, Xu S, Fang H, Weintraub A . Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China. Anaerobe. 2014; 30:65-9. DOI: 10.1016/j.anaerobe.2014.08.015. View